GLSI
$23.70
Greenwich Lifesciences
$.08
.34%
GLSI
Earnings Whisper ®
N/A
1st Quarter March 2026
Consensus:  ($0.33)
Revenue:  N/A
Tuesday
May 19
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when GLSI reports earnings?
Beat
Meet
Miss

Where is GLSI's stock price going from here?
Up
Flat
Down
Stock chart of GLSI
Analysts
Summary of analysts' recommendations for GLSI
Score
Grade
Pivots
Resistance
$26.74
$25.82
$24.76

$23.84

Support
$22.78
$21.86
$20.80
Tweet
Growth
Description
Greenwich LifeSciences Inc. is a clinical stage biopharmaceutical company focuses on the development of cancer immunotherapies for breast cancer and other human epidermal growth factor. The company's product candidate includes GP2, which is in clinical stage. Greenwich LifeSciences Inc.is based in Stafford, Texas.
›